U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H37N5O10
Molecular Weight 483.5139
Optical Activity UNSPECIFIED
Defined Stereocenters 15 / 15
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BEKANAMYCIN

SMILES

[H][C@]3(O[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O[C@@]2([H])O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O)[C@H]1O)O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N

InChI

InChIKey=SKKLOUVUUNMCJE-FQSMHNGLSA-N
InChI=1S/C18H37N5O10/c19-2-6-11(26)12(27)9(23)17(30-6)32-15-4(20)1-5(21)16(14(15)29)33-18-13(28)8(22)10(25)7(3-24)31-18/h4-18,24-29H,1-3,19-23H2/t4-,5+,6+,7+,8-,9+,10+,11+,12+,13+,14-,15+,16-,17+,18+/m0/s1

HIDE SMILES / InChI

Molecular Formula C18H37N5O10
Molecular Weight 483.5139
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 15 / 15
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Sources: www.drugfuture.com/mt/bekanamycin-sulfate.pdf
Curator's Comment: description was created based on several sources, including: http://www.drugfuture.com/chemdata/Kanamycin.html https://farmaci.agenziafarmaco.gov.it/aifa/servlet/PdfDownloadServlet?pdfFileName=footer_000902_022729_FI.pdf&retry=0&sys=m0b1l3

Bekanamycin is an aminoglycoside and is a congener of kanamycin. It is given topically as the sulfate for the treatment of eye infections. It is reported to be more toxic than kanamycin A. Antibiotic complex produced by Streptomyces kanamyceticus Okami & Umezawa from Japanese soil. There are no known interactions with other drugs.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
180.0 nM [Kd]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Visucloben antibiotico

Approved Use

It is used in the treatment of eye infections.
PubMed

PubMed

TitleDatePubMed
[Experimental study on renal tolerability of aminoglycosides butirosin and bekanamycin (author's transl)].
1980
Antimycobacterial activity of phorbol esters from the fruits of Sapium indicum.
2003 Apr
In vitro and in vivo activities of ruthenium(II) phosphine/diimine/picolinate complexes (SCAR) against Mycobacterium tuberculosis.
2013
Patents

Patents

Sample Use Guides

In Vivo Use Guide
One drop 4 times per day
Route of Administration: Other
B. subtilis 168 (strain I) and S. epidermidis ATCC 12228 (strain X) are both susceptible to Bekanamycin (MIC = 4 ug/mL and 0.5 ug/mL, respectively).
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:59:37 GMT 2023
Edited
by admin
on Fri Dec 15 15:59:37 GMT 2023
Record UNII
15JT14C3GI
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BEKANAMYCIN
INN   WHO-DD  
INN  
Official Name English
Bekanamycin [WHO-DD]
Common Name English
(1R,2S,3S,4R,6S)-4,6-DIAMINO-3-((3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL)OXY)-2-HYDROXYCYCLOHEXYL 2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSIDE
Common Name English
KANAMYCIN B [MI]
Common Name English
NK-1006
Code English
KANAMYCIN B
MI  
Common Name English
NK 1006
Code English
bekanamycin [INN]
Common Name English
AMINODEOXYKANAMYCIN
Common Name English
NEBRAMYCIN V
Common Name English
.ALPHA.-D-GLUCOPYRANOSIDE, (1R,2S,3S,4R,6S)-4,6-DIAMINO-3-((3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL)OXY)-2-HYDROXYCYCLOHEXYL 2,6-DIAMINO-2,6-DIDEOXY-
Common Name English
TOBRAMYCIN IMPURITY A [EP IMPURITY]
Common Name English
ANTIBIOTIC DERIVED FROM STREPTOMYCES KANAMYCETICUS. KANAMYCIN B
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C2363
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
WHO-ATC J01GB13
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
WHO-VATC QJ01GB13
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
Code System Code Type Description
DRUG CENTRAL
1520
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
CAS
4696-76-8
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
MESH
C001495
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
DRUG BANK
DB13673
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
PUBCHEM
439318
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
ChEMBL
CHEMBL2105594
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
NCI_THESAURUS
C65248
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
CHEBI
28098
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
FDA UNII
15JT14C3GI
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
CHEBI
58549
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
INN
2838
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
ECHA (EC/EINECS)
225-170-5
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
EPA CompTox
DTXSID8023185
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
MERCK INDEX
m6599
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY Merck Index
EVMPD
SUB05684MIG
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
SMS_ID
100000086135
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
WIKIPEDIA
BEKANAMYCIN
Created by admin on Fri Dec 15 15:59:37 GMT 2023 , Edited by admin on Fri Dec 15 15:59:37 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
IMPURITY -> PARENT
Amount not specified.
IMPURITY -> PARENT
Amount not specified.
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY